Funding without focus requirement led to ground-breaking research
By offering funding for up to nine years, MIMS could recruit promising researchers from across the world – Emmanuelle Charpentier’s discovery shows that the strategy was successful.
One of the people celebrated today in the digital ceremony that replaces the Nobel Prize ceremony is Emmanuelle Charpentier. Together with Jennifer A. Doudna, she is this year’s winner of the Nobel Prize in Chemistry. Their discoveries of the genetic scissors CRISPR/Cas9 have revolutionised molecular life sciences by making it possible to change the genome of animals, plants and micro-organisms.
When Emmanuelle Charpentier, who is today a professor, scientific leader and head of the Max Planck Unit for the Science of Pathogens in Berlin, made her ground-breaking discoveries, she was working at the MIMS laboratory at Umeå University. She was one of the first team leaders the laboratory recruited in 2008.
Oliver Billker, who is a professor at the Department of Molecular Biology at Umeå University and the current head of MIMS, describes how the funding from the Swedish Research Council opened a new door to recruiting researchers.
“By offering grants lasting up to nine years, we can attract the most promising researchers from anywhere in the world to apply. Here, they have the opportunity to build up a high-quality research environment and the freedom to tackle big and important questions.”
“Emmanuelle Charpentier’s discovery shows that this plan succeeded,” says Oliver Billker.
“When she started her laboratory at MIMS, her potential as a scientist was apparent, but the enormous significance that her ongoing research would quickly develop could not have been predicted.”
MIMS still receives funding from the Swedish Research Council. Oliver Billker underlines the importance of grants without a required focus, how this stimulates creative and curiosity-driven research.
“Many of the best scientists are motivated by their curiosity. Their research often leads to profound discoveries, the importance of which was not predictable. The discovery of CRISPR/Cas9 is a great example. The recent successes in vaccine development demonstrate that science can deliver products at great speed. However, this only works because of the enormous body of knowledge generated by previous curiosity-driven research.”
Emmanuelle Charpentier worked at MIMS, the Laboratory for Molecular Infection Medicine Sweden, at Umeå University with funding from the Swedish Research Council during 2008–2013. MIMS is one of the nodes in the Nordic network operated by the European Molecular Biology Laboratory, EMBL.
This year’s Nobel Prizes are given out in the prize winners’ home countries. On Monday 7 December, Emmanuelle Charpentier received her diploma and medal at the Swedish Embassy in Berlin.
On Tuesday 8 December, she and Jennifer A. Doudna gave their Nobel lectures External link..
On 10 December, all Nobel Prize winners are celebrated simultaneously at a digital ceremony broadcast External link. from Stockholm City Hall.
Pdf / Printout
MORE WITHIN THE SAME SUBJECT AREA
Published 17 June 2022
During 2022, the Swedish Research Council’s scientific councils and committees will produce research reviews within their respective subject areas. This autumn, we will introduce the option of making comments on the first draft.
Published 17 June 2022
During spring and summer, the Swedish Research Council’s scientific councils and committees have produced proposals for research surveys within their various scientific fields. Openness, transparency and solid establishment in the research community ...
Published 7 June 2022
On 31 May, Formas, Forte, the Swedish Research Council and Vinnova presented a further development of the joint proposal for a model for quality-based resource allocation that they presented in 2021. The proposal is the result of a joint Government m...